CCO Treatment Updates

Clinical Controversies in the Treatment of Anemia: Appropriate Use of ESAs in a Time of Change

Slideset Module

Clinical Controversies in the Treatment of Anemia: Appropriate Use of ESAs in a Time of Change

Program Director:
George Rodgers, MD, PhD

Faculty:

Jeffrey Crawford, MD headshotDavid H. Henry, MD headshotLee Schwartzberg, MD, FACP headshot
  • Jeffrey Crawford, MD
  • David H. Henry, MD
  • Lee Schwartzberg, MD, FACP

CME CREDIT INFORMATION

Release Date: 07/30/08

Expiration Date: 07/29/09


Physicians: maximum of 2.5 AMA PRA Category 1 Credit(s)™

Registered Nurses: 2.5 Nursing CE credits

Status: Please log in to view status


Expert faculty discuss an overview of the etiology and epidemiology of anemia, the role of iron therapy in treating cancer-related anemia, and future directions for ESA therapy in these patients as determined by guidelines recommending their use and recent data from clinical trials and meta-analyses. A case-based presentation also is included to explore the appropriate use of ESAs in oncology patients.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Describe the biology of anemia and its clinical impact on patients with cancer
  • Discuss efficacy and safety data related to appropriate use of erythropoiesis-stimulating agents (ESAs) in patients with cancer
  • Evaluate the possible risks and benefits of ESAs in the management of anemia in the oncology setting
  • Discuss recent updates from regulatory agencies and changes to practice guidelines regarding the clinical utility of ESAs

Clinical Controversies in the Treatment of Anemia: Appropriate Use of ESAs in a Time of Change


Download slides on the optimal treatment of oncology patients with anemia. Presentations include discussions on the etiology and epidemiology of anemia, the appropriate use of ESAs and the recent changes in guidelines recommending their use in oncology, the role of transfusion, and the future direction of ESA therapy.


Format: Microsoft PowerPoint (.ppt) | File size: 3,482 KB
Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.

Jointly sponsored by Postgraduate Institute for Medicine and Clinical Care Options, LLC.

Contact Info

Supported by an educational donation from

Educational grants support only the CME-certified components of this program.